Dashboard
1
Poor Management Efficiency with a low ROCE of 1.41%
- The company has been able to generate a Return on Capital Employed (avg) of 1.41% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -16.84% and Operating profit at -157.83% over the last 5 years
3
Flat results in Mar 25
4
With ROE of 0.04%, it has a fair valuation with a 0.87 Price to Book Value
5
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,211 Million (Small Cap)
2,248.00
NA
1.51%
-0.22
0.24%
0.85
Revenue and Profits:
Net Sales:
198 Million
(Quarterly Results - Sep 2025)
Net Profit:
5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.12%
0%
-2.12%
6 Months
-11.7%
0%
-11.7%
1 Year
-3.74%
0%
-3.74%
2 Years
66.03%
0%
66.03%
3 Years
-15.26%
0%
-15.26%
4 Years
-32.56%
0%
-32.56%
5 Years
-26.17%
0%
-26.17%
Guangdong Vtr Bio-Tech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-16.84%
EBIT Growth (5y)
-157.83%
EBIT to Interest (avg)
-1.20
Debt to EBITDA (avg)
0.91
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.30
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
154.32%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.41%
ROE (avg)
2.03%
Valuation key factors
Factor
Value
P/E Ratio
2248
Industry P/E
Price to Book Value
0.87
EV to EBIT
-107.24
EV to EBITDA
15.12
EV to Capital Employed
0.83
EV to Sales
1.98
PEG Ratio
NA
Dividend Yield
1.49%
ROCE (Latest)
-0.77%
ROE (Latest)
0.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
198.10
212.60
-6.82%
Operating Profit (PBDIT) excl Other Income
3.90
34.20
-88.60%
Interest
0.10
0.60
-83.33%
Exceptional Items
-2.00
0.50
-500.00%
Consolidate Net Profit
4.90
9.50
-48.42%
Operating Profit Margin (Excl OI)
19.60%
9.00%
1.06%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -6.82% vs 5.04% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -48.42% vs 90.00% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
823.20
785.70
4.77%
Operating Profit (PBDIT) excl Other Income
115.40
87.90
31.29%
Interest
7.10
3.50
102.86%
Exceptional Items
5.20
-1.80
388.89%
Consolidate Net Profit
32.00
1.20
2,566.67%
Operating Profit Margin (Excl OI)
-1.40%
-38.20%
3.68%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 4.77% vs -32.13% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 2,566.67% vs -96.80% in Dec 2023
About Guangdong Vtr Bio-Tech Co., Ltd. 
Guangdong Vtr Bio-Tech Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






